CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDER’S EQUITY (UNAUDITED) - USD ($)		Total	Common Class B	Common Class A	Common Stock Common Class B		Additional Paid-in Capital	Accumulated Deficit
Share outstanding, beginning balance (in shares) at Dec. 31, 2022	[1]				12,500,000
Shareholder's equity, beginning balance at Dec. 31, 2022	[1]	$ 8,961			$ 1,250		$ 23,750	$ (16,039)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		(300)						(300)
Share outstanding, ending balance (in shares) at Mar. 31, 2023	[1]				12,500,000
Shareholder's equity, ending balance at Mar. 31, 2023	[1]	8,661			$ 1,250		23,750	(16,339)
Share outstanding, beginning balance (in shares) at Dec. 31, 2022	[1]				12,500,000
Shareholder's equity, beginning balance at Dec. 31, 2022	[1]	8,961			$ 1,250		23,750	(16,039)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		3,565,636
Share outstanding, ending balance (in shares) at Jun. 30, 2023					12,500,000
Shareholder's equity, ending balance at Jun. 30, 2023		(19,439,305)			$ 1,250		0	(19,440,555)
Share outstanding, beginning balance (in shares) at Mar. 31, 2023	[1]				12,500,000
Shareholder's equity, beginning balance at Mar. 31, 2023	[1]	8,661			$ 1,250		23,750	(16,339)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion of Class A ordinary shares to redemption amount		(39,938,902)					(16,948,750)	(22,990,152)
Net income (loss)		3,565,936						3,565,936
Share outstanding, ending balance (in shares) at Jun. 30, 2023					12,500,000
Shareholder's equity, ending balance at Jun. 30, 2023		(19,439,305)			$ 1,250		0	(19,440,555)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Adjustments to Additional Paid in Capital, Warrant Issued		14,300,000					14,300,000
Adjustments to Additional Paid in Capital, Fair Value		2,625,000					2,625,000
Share outstanding, beginning balance (in shares) at Dec. 31, 2023			12,500,000		12,500,000
Shareholder's equity, beginning balance at Dec. 31, 2023		(20,264,060)			$ 1,250		0	(20,265,310)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion of Class A ordinary shares to redemption amount		(6,848,901)						(6,848,901)
Net income (loss)		6,393,390						6,393,390
Share outstanding, ending balance (in shares) at Mar. 31, 2024					12,500,000
Shareholder's equity, ending balance at Mar. 31, 2024		(20,719,571)			$ 1,250		0	(20,720,821)
Share outstanding, beginning balance (in shares) at Dec. 31, 2023			12,500,000		12,500,000
Shareholder's equity, beginning balance at Dec. 31, 2023		(20,264,060)			$ 1,250		0	(20,265,310)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		12,978,757
Share outstanding, ending balance (in shares) at Jun. 30, 2024			12,500,000	50,000,000	12,500,000	[1]
Shareholder's equity, ending balance at Jun. 30, 2024	[1]	(21,092,994)			$ 1,250		0	(21,094,244)
Share outstanding, beginning balance (in shares) at Mar. 31, 2024					12,500,000
Shareholder's equity, beginning balance at Mar. 31, 2024		(20,719,571)			$ 1,250		0	(20,720,821)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion of Class A ordinary shares to redemption amount		(6,958,790)					0	(6,958,790)
Net income (loss)		6,585,367						6,585,367
Share outstanding, ending balance (in shares) at Jun. 30, 2024			12,500,000	50,000,000	12,500,000	[1]
Shareholder's equity, ending balance at Jun. 30, 2024	[1]	$ (21,092,994)			$ 1,250		$ 0	$ (21,094,244)

[1] On April 25, 2023, the Company consummated the sale of Over-Allotment Units pursuant to the underwriters’ partial exercise of their over-allotment option. All share amounts have been retroactively restated to reflect the share surrender and share recapitalization events and the share forfeitures (see Note 4).